Synopsis of recent research by authors named "Haoran Gu"
- Haoran Gu's recent research primarily focuses on the predictive value of specific genetic mutations and natural modulators in the context of disease treatment, particularly in cancer and neurodegenerative disorders.
- Key findings include the determination that ZFHX4 mutations may serve as biomarkers for the efficacy of immune checkpoint inhibitors in lung cancer and melanoma, while Irisin emerges as a potential therapeutic target in Alzheimer’s disease.
- Additionally, Gu's work on the Nrf2 pathway highlights its significant role in chronic disease intervention, emphasizing the importance of natural products in drug development strategies.